HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICCR Game Plan Unchanged: Remove Trade Barriers Without Changing Regulations

This article was originally published in The Rose Sheet

Executive Summary

FDA and U.S. industry members are gearing up for the upcoming annual International Cooperation on Cosmetics Regulations meeting, where they plan to work with other members to “remove regulatory barriers” between nations without calling for modifications to existing regulations.

You may also be interested in...



ICCR To Open Portion Of Annual Meeting To “Interested Parties,” NGOs

The International Cooperation for Cosmetics Regulation will allow representatives from consumer groups, NGOs, non-member regulators and other “interested parties” to attend an open session during its fifth annual meeting in Paris, according to FDA representatives.

ICCR To Open Portion Of Annual Meeting To “Interested Parties,” NGOs

The International Cooperation for Cosmetics Regulation will allow representatives from consumer groups, NGOs, non-member regulators and other “interested parties” to attend an open session during its fifth annual meeting in Paris, according to FDA representatives.

Nanotech Programs In U.S., EU, Move Regs Closer To Global Model

The regulation of nanotechnology continues moving towards a harmonized model as agencies on both sides of the Atlantic announce new funds and collaborations towards safety assessments.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017536

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel